Last update :
19/11/2024
Research teams - Pharmaceutical Research and Development, Pfizer Inc   pdf  
United States of America
Pharmaceutical laboratory
Pharmaceutical Research and Development, Pfizer Inc
Andover
Email
References   References   (2)  
1
Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E (Sarah.Weiser@pfizer.com)
J Oncol Pharm Practice - 2023 - ;29,3:
2
Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E. (Sarah.Weiser@pfizer.com)
J Oncol Pharm Practice - 2022 - ;29, 5: 1032-1043

List of drugs   Molecules studied   (2)  
Anticancer drug injection Bevacizumab
Anticancer drug injection Trastuzumab

  Mentions Légales